These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 30564512)
1. Retinal Toxicity of Intravitreal Injection of Ziv-Aflibercept in Albino Rabbits. Ramon D; Shahar J; Massarweh A; Man I; Perlman I; Loewenstein A Transl Vis Sci Technol; 2018 Nov; 7(6):23. PubMed ID: 30564512 [TBL] [Abstract][Full Text] [Related]
2. Intravitreal Trimethoprim and Sulfamethoxazole Toxicity to the Retina of Albino Rabbits. Mazza O; Habot-Wilner Z; Shahar J; Mann I; Loewenstein A; Perlman I Transl Vis Sci Technol; 2018 Nov; 7(6):2. PubMed ID: 30479873 [TBL] [Abstract][Full Text] [Related]
3. Retinal toxicity of intravitreal rituximab in albino rabbits. Habot-Wilner Z; Shahar J; Zemel E; Loewenstein A; Perlman I Retina; 2013 Mar; 33(3):649-56. PubMed ID: 22990324 [TBL] [Abstract][Full Text] [Related]
4. Infliximab exerts a dose-dependent effect on retinal safety in the albino rabbit. Zayit-Soudry S; Vainer I; Zemel E; Mimouni M; Rabena M; Pieramici DJ; Perlman I; Loewenstein A Doc Ophthalmol; 2017 Dec; 135(3):175-185. PubMed ID: 28825191 [TBL] [Abstract][Full Text] [Related]
5. Retinal toxicity of commercially available intravitreal ketorolac in albino rabbits. Komarowska I; Heilweil G; Rosenfeld PJ; Perlman I; Loewenstein A Retina; 2009 Jan; 29(1):98-105. PubMed ID: 18626418 [TBL] [Abstract][Full Text] [Related]
6. Safety of intravitreal clindamycin in albino rabbit eyes. Habot-Wilner Z; Mazza O; Shahar J; Massarweh A; Mann I; Loewenstein A; Perlman I Doc Ophthalmol; 2017 Oct; 135(2):133-146. PubMed ID: 28744691 [TBL] [Abstract][Full Text] [Related]
7. Safety of intravitreal bevacizumab in the developing rabbit retina. Zayit-Soudry S; Zemel E; Barak A; Perlman I; Loewenstein A Retina; 2011 Oct; 31(9):1885-95. PubMed ID: 21799464 [TBL] [Abstract][Full Text] [Related]
8. Safety and Bioavailability of Complete and Half-Dose Intravitreal Ziv-Aflibercept in an Experimental Model: Contralateral Eye Study. Lashay A; Delrish E; Ashrafi E; Movassat M; Asadi-Amoli F; Dinarvand R; Abrishami M Ophthalmic Surg Lasers Imaging Retina; 2019 Dec; 50(12):785-790. PubMed ID: 31877224 [TBL] [Abstract][Full Text] [Related]
9. Electrophysiologic and retinal penetration studies following intravitreal injection of bevacizumab (Avastin). Shahar J; Avery RL; Heilweil G; Barak A; Zemel E; Lewis GP; Johnson PT; Fisher SK; Perlman I; Loewenstein A Retina; 2006 Mar; 26(3):262-9. PubMed ID: 16508424 [TBL] [Abstract][Full Text] [Related]
10. Physiological and toxicological effects of cefuroxime on the albino rabbit retina. Shahar J; Zemel E; Perlman I; Loewenstein A Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):906-14. PubMed ID: 22159021 [TBL] [Abstract][Full Text] [Related]
18. INTRAVITREAL ZIV-AFLIBERCEPT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: 52-Week Results. de Oliveira Dias JR; Costa de Andrade G; Kniggendorf VF; Novais EA; Takahashi VKL; Maia A; Meyer C; Watanabe SES; Farah ME; Rodrigues EB Retina; 2019 Apr; 39(4):648-655. PubMed ID: 29232334 [TBL] [Abstract][Full Text] [Related]
19. FLATTENING OF A TREATMENT-RESISTANT RETINAL PIGMENT EPITHELIAL DETACHMENT AFTER A SINGLE INTRAVITREAL INJECTION OF ZIV-AFLIBERCEPT. Yogi R; Stewart M; Chhablani J Retin Cases Brief Rep; 2017 Spring; 11(2):111-113. PubMed ID: 27078613 [TBL] [Abstract][Full Text] [Related]
20. Long-term safety and efficacy of ziv-aflibercept in retinal diseases. Mansour AM; Ashraf M; Dedhia CJ; Charbaji A; Souka AAR; Chhablani J Br J Ophthalmol; 2017 Oct; 101(10):1374-1376. PubMed ID: 28270485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]